Wilmington, United States
BioCertica, founded in 2019, is a pioneering biotechnology company that has positioned itself as Africa's first digital biobank. Headquartered in the United States, it merges advanced genetic testing with encryption technology to deliver secure, actionable insights from DNA tests. With its slogan, "The first African-based Genetic company to introduce cutting-edge methodology to generate your DNA test results," BioCertica emphasizes its innovative approach.
Operating in the Analytics and Biotechnology industries, BioCertica offers a suite of DNA tests designed to empower individuals to make informed decisions about their health and wellness. A key differentiator lies in its commitment to privacy, ensuring that users maintain control over their genetic information without third-party sales.
The company recently received a $50.00K Grant investment in September 2023 from Investing In Innovation Africa. This investment underscores confidence in BioCertica's potential to reshape the genetic testing landscape in Africa.
